Royal Bank of Canada »

BioCryst Pharmaceuticals shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2011-09-30 $6.0k 2.3k 2.59
2011-06-30 $5.0k 1.2k 4.17

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Bank Of Montreal Cadcom (BMO)
Bk Nova Cad (BNS)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Ishares Tr Russell 2000 Etf (IWM)

View all positions for Royal Bank of Canada

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals